Informed weight management

Follow-up during treatment: what happens after the prescription

Learn how medical review, symptom monitoring, and sustainable habits connect in a weight-management journey.

Produced byLevia editorial team2 min readUpdated on September 04, 2026

Every figure linked to its source

Follow-up during treatment: what happens after the prescription

Treatment happens between appointments

What a person can sustain in daily life matters as much as the written plan. Follow-up turns information into safer, practical decisions.

A prescription, when indicated, does not close the assessment. It begins a period in which response, tolerability, and routine need to be reviewed together.

What can change after treatment starts

Sleep, food, activity, other medicines, and health conditions may change over time. Follow-up adds context and prevents decisions based only on anxiety about the scale.

It is also the place to clarify administration, storage, and warning signs. Small unanswered questions can affect safety and continuity.

Habits are not a decorative add-on

Medicines do not replace a workable routine. Nutrition, movement, rest, and behavioral strategies are part of long-term management. The goal is not perfection; it is a pattern that can continue through difficult weeks.

How to prepare for a review

Record symptoms, questions, changes in routine, and other medicines. Bring a multi-week trend rather than a single measurement when possible. The goal is useful information, not a perfect report card.

A connected journey starts with complete information

Complete the initial questionnaire and continue to an individual assessment. An assessment does not guarantee a prescription.

Explore the Levia journey

Continuity is part of the outcome

A strategy works in real life when it can be understood, monitored, and adjusted. The best plan is not the most intense one; it balances benefit, risk, context, and continuity.

FAQ

Frequently asked questions

Every figure linked to its source

Sources and references

Read the original materials used to prepare this content.

  1. Diabetology & Metabolic SyndromeBrazilian evidence-based guideline for the management of obesity and prevention of cardiovascular disease
  2. World Health OrganizationWHO guideline on GLP-1 medicines for obesity

Take your questions to partner doctors

Tell us a little about your health to begin an individual assessment. An assessment does not guarantee a prescription.

Start my assessment